Plexium is a biotechnology research company focused on targeted protein degradation (TPD)
Plexium is a biotechnology research company focused on targeted protein degradation (TPD). It develops small-molecule therapeutics, including monovalent direct degraders and molecular glues, aimed at first-in-class and best-in-class treatments for high unmet medical needs.